These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 27418384)
1. Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection. Zhang X; Lv L; Ouyang X; Zhang S; Fang J; Cai L; Li D Cancer Med; 2016 Sep; 5(9):2180-9. PubMed ID: 27418384 [TBL] [Abstract][Full Text] [Related]
2. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
3. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857 [TBL] [Abstract][Full Text] [Related]
4. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival. Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778 [TBL] [Abstract][Full Text] [Related]
5. Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma. Zhu M; Yin F; Fan X; Jing W; Chen R; Liu L; Zhang L; Liu Y; Liang Y; Bu F; Tong X; Zheng H; Zhao J; Guo Y Oncogene; 2015 Mar; 34(11):1420-31. PubMed ID: 24681951 [TBL] [Abstract][Full Text] [Related]
6. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin. Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068 [TBL] [Abstract][Full Text] [Related]
7. F221Y mutation in hepatitis B virus reverse transcriptase is associated with hepatocellular carcinoma prognosis following liver resection. Li H; Jia J; Wang M; Wang H; Gu X; Fang M; Gao C Mol Med Rep; 2017 May; 15(5):3292-3300. PubMed ID: 28339094 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma. Ke RS; Zhang K; Lv LZ; Dong YP; Pan F; Yang F; Cai QC; Jiang Y Int J Biol Macromol; 2019 May; 129():140-151. PubMed ID: 30731163 [TBL] [Abstract][Full Text] [Related]
9. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069 [TBL] [Abstract][Full Text] [Related]
10. Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma. Liu Y; Hu C; Zhu WB; Xu WX; Li ZY; Lin Y; Cai J; Liang JK; Zhu X; Gao ZL; Yan GM; Peng L Cell Physiol Biochem; 2018; 49(3):1007-1018. PubMed ID: 30196292 [TBL] [Abstract][Full Text] [Related]
11. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma. Zhang X; You Q; Zhang X; Chen X Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582 [TBL] [Abstract][Full Text] [Related]
12. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960 [TBL] [Abstract][Full Text] [Related]
13. The expression and role of lncRNA AX800134 in hepatitis B virus-related hepatocellular carcinoma. Zuo K; Kong L; Xue D; Yang Y; Xie L Virus Genes; 2018 Aug; 54(4):475-483. PubMed ID: 29789998 [TBL] [Abstract][Full Text] [Related]
14. Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma. Mathews P; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Lyu H; Jaffee E; Zheng L; Yu E; Lee YJ Ann Surg Oncol; 2013 Apr; 20(4):1216-22. PubMed ID: 23104706 [TBL] [Abstract][Full Text] [Related]
15. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan. Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029 [TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Yao M; Zhao J; Lu F Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling. Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586 [TBL] [Abstract][Full Text] [Related]
18. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1. Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease. Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]